Open Access
Analysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma
Author(s) -
Thomas C. Booth,
Timothy J. Larkin,
Yinyin Yuan,
Mikko I. Kettunen,
Sarah Dawson,
Daniel Scoffings,
Holly C. Canuto,
Sarah L. Vowler,
Heide L. Kirschenlohr,
M. Hobson,
Florian Markowetz,
Sarah Jefferies,
Kevin M. Brindle
Publication year - 2017
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0176528
Subject(s) - feature selection , medicine , random forest , artificial intelligence , glioblastoma , pattern recognition (psychology) , prospective cohort study , radiology , computer science , cancer research
Purpose To develop an image analysis technique that distinguishes pseudoprogression from true progression by analyzing tumour heterogeneity in T 2 -weighted images using topological descriptors of image heterogeneity called Minkowski functionals (MFs). Methods Using a retrospective patient cohort ( n = 50), and blinded to treatment response outcome, unsupervised feature estimation was performed to investigate MFs for the presence of outliers, potential confounders, and sensitivity to treatment response. The progression and pseudoprogression groups were then unblinded and supervised feature selection was performed using MFs, size and signal intensity features. A support vector machine model was obtained and evaluated using a prospective test cohort. Results The model gave a classification accuracy, using a combination of MFs and size features, of more than 85% in both retrospective and prospective datasets. A different feature selection method (Random Forest) and classifier (Lasso) gave the same results. Although not apparent to the reporting radiologist, the T 2 -weighted hyperintensity phenotype of those patients with progression was heterogeneous, large and frond-like when compared to those with pseudoprogression. Conclusion Analysis of heterogeneity, in T 2 -weighted MR images, which are acquired routinely in the clinic, has the potential to detect an earlier treatment response allowing an early change in treatment strategy. Prospective validation of this technique in larger datasets is required.